002644.SZ
Lanzhou Foci Pharmaceutical Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 8.18
−0.24%Margins
Gross margin
34.8%
EBITDA margin
13.6%
EBIT margin
7.7%
Net margin
5.8%
FCF margin
24.1%
2.8%
Return on equity
2.0%
Return on assets
3.8%
Return on invested capital
0.36x
Asset turnover
CNY 231.8M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026